Latest News and Press Releases

RALEIGH, Carolina do Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ:PRAH) anunciou hoje a nomeação do Doutor Glen Stettin para o Conselho de Administração da Empresa,...

RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) hari mengumumkan pelantikan Glen Stettin, M.D. kepada Lembaga Pengarah Syarikat, berkuat kuasa pada 14...

미국 노스캐롤라이나주 롤리, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 글렌 스테틴(Glen Stettin, 일반의)이 2020년 9월 14일부로 이사회 임원으로 선임됐다고 발표했다. 콜린 섀넌(Colin Shannon) PRA...

ノースカロライナ州ローリー発, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences, Inc.) (NASDAQ:PRAH) は本日、2020年9月14日付でグレン･ステッティン医学博士 (Glen Stettin, M.D.) を同社取締役に任命したことを発表した。 ...

RALEIGH, North Carolina, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) hat heute die Ernennung von Dr. Glen Stettin zum Verwaltungsratsmitglied des Unternehmens mit...

RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective...

Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million...

RALEIGH, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its second quarter 2020 results after the market closes on Thursday, August 6, 2020. The...

RALEIGH, Carolina del Norte, June 18, 2020 (GLOBE NEWSWIRE) -- Entre 2007 y 2017, la Administración de Alimentos y Medicamentos (FDA) de Estados Unidos1, aprobó 78 nuevos agentes para cáncer de...

ノースカロライナ州ローリー発, June 19, 2020 (GLOBE NEWSWIRE) -- 2007～2017年の期間、米国食品医薬品局 (U.S. Food and Drug Administration) 1は78件の成人がん治療新薬を承認したが、このうち小児がんへの有効性を判定された治療薬はなかった。 8月18日にRACE (Research to Accelerate...